Skip to main content
Premium Trial:

Request an Annual Quote

Scottish Antisense Firm ExpressOn Closing After Failed Funding Deal with MMI

NEW YORK, April 14 (GenomeWeb News) - Scottish company ExpressOn, which makes gene-blocking antisense products, is in the process of shutting down operations in the wake of a failed deal with Cambridge-based Medical Marketing International to fund further commercialization of ExpressOn's products, according to a news report.

 

All seven of ExpressOn's staff have been laid off, according to the report, which appears in the online version of the International Herald Tribune.

 

"The whole round was contingent on closing at £1 million ($1.9 million)," Peter Estibeiro, ExpressOn CEO told The Herald. "Seventy percent of the cash had been secured, including 300,000 from the Scottish Co-Investment Fund. MMI's official position is that the decision is not a definitive one, but directors have lost confidence that the deal will close and have taken the decision to begin winding-up proceedings," he said.

 

The chance of the deal actually coming through is "vanishingly small," Estibeiro said.

 

ExpressOn did not immediately return phone calls seeking comment.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.